Hoth Therapeutics Stock Price - HOTH

4.475
-0.045 (-1.00%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
Level 1 Starter
Monthly Subscription
for only
$15.87
VAT not included
Company Name Stock Ticker Symbol Market Type
Hoth Therapeutics Inc HOTH NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.11 2.49% 4.52 4.41 4.6572 4.41 4.41 18:02:24
Bid Price Ask Price Spread Spread % News
3.68 4.99 1.31 26.25% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
48 5,868 $ 4.51 $ 26,454 67,353 3.26 - 9.07
Last Trade Time Type Quantity Stock Price Currency
16:00:00 79 $ 4.475 USD

Hoth Therapeutics Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 45.74M 10.12M $ -2.50M -0.26 - 9.09M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 5.00 10.10%

more financials information »

Hoth Therapeutics News

Loading Messages....

Latest HOTH Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical HOTH Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week5.005.124.404.5832,916-0.48-9.6%
1 Month4.907.203.754.8590,403-0.38-7.76%
3 Months4.787.253.755.0651,326-0.26-5.44%
6 Months6.507.253.264.9231,778-1.98-30.46%
1 Year7.819.073.265.3824,429-3.29-42.13%
3 Years10.2813.883.265.4725,625-5.76-56.03%
5 Years10.2813.883.265.4725,625-5.76-56.03%

Hoth Therapeutics Description

Hoth Therapeutics Inc is a development stage biopharmaceutical company. It is focused on targeted therapeutics for patients suffering from conditions such as atopic dermatitis, also known as eczema. The company owns the BioLexa Platform which combines an FDA-approved zinc chelator with one or more approved antibiotics in a topical dosage form to address unchecked eczema flare-ups.


Your Recent History
NASDAQ
HOTH
Hoth Thera..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.